Tim P. Green

<i>N</i>-(5-Chloro-1,3-benzodioxol-4-yl)-7-[2-(4-methylpiperazin-1-yl)ethoxy]-5- (tetrahydro-2<i>H</i>-pyran-4-yloxy)quinazolin-4-amine, a Novel, Highly Selective, Orally Available, Dual-Specific c-Src/Abl Kinase Inhibitor

Laurent Hennequin, J M Allen, J. Breed et al. · Journal of Medicinal Chemistry · 2006 · 358 citations · Full text

Drug Target, Pharmacotherapy, Pharmaceutical Chemistry +16

Elevated Src activity promotes cellular invasion and motility in tamoxifen resistant breast cancer cells

Stephen Hiscox, L. Morgan, Tim P. Green et al. · Breast Cancer Research and Treatment · 2005 · 272 citations

Breast Oncology, Medicine, Elevated Src Activity +7

Preclinical anticancer activity of the potent, oral Src inhibitor AZD0530

Tim P. Green, Mike Fennell, Robin Whittaker et al. · Molecular Oncology · 2009 · 254 citations · Full text

Discovery of a New Class of Anilinoquinazoline Inhibitors with High Affinity and Specificity for the Tyrosine Kinase Domain of c-Src

Patrick A. Plé, Tim P. Green, Laurent Hennequin et al. · Journal of Medicinal Chemistry · 2004 · 167 citations · Full text

Drug Target, Anilinoquinazoline Inhibitors, Pharmacotherapy +18

Saracatinib Impairs Head and Neck Squamous Cell Carcinoma Invasion by Disrupting Invadopodia Function

Amanda G. Ammer, Laura C. Kelley, Karen E. Hayes et al. · Journal of Cancer Science & Therapy · 2009 · 79 citations · Full text

Saracatinib Impairs Head, Src Kinase, Malignant Disease +15